yoshida
medicine
chung
ishioka
shimadzu
iodinated
TK
decreased
umn
han
gun
aid
presumably
fang
faculty
2008
missimer
profile
crossref
acryloyl
sci
form
shown
yuan
neutral
third
next
847
tetrazolium
N2
100
our
methoxy
2009
beyond
determining
depend
147
CF3
thu
distant
irina
radiotrac
applicable
fast
highest
serve
responding
stability
high
1686
kit
active
purity
JCF
qst
saturated
selectivity
lausanne
line
chiba
via
considered
S1
KM
reagent
121
corresponding
evaluation
oncogenic
reference
monmouth
label
methyl
lateral
rapid
university
sncl
bakari
riely
rep
monosodium
scholarship
result
influenceinhibitory
mixture
patent
derivative
possemato
buffered
nitro
japan
penetration
ratio
surrogate
nuclear
adenocarcinoma
SLC
acetone
t790mgroup
case
junction
induced
chen
lee
9793
eiheiji
9777
life
148
figure1
186
urine
bound
stirring
crystal
intact
new
synthesizing
doe
FPN
9842
filtered
assay
draft
body
8641
czernin
thebiodistribution
3896
all
consent
metal
sparr
figure
JNM
dimethoxy
NJ
overnight
selected
postinjection
radioactivity
possible
RGD
BIRC
127
791
N4
health
156
157
fundamental
ARC
advantage
identity
multistep
IC50
ddy
intermediate
450
enomoto
S8
125I
moderate
chan
108
performed
H2
care
initiative
positive
paired
finck
brco1686
but
eliminated
each
400
cause
ion
injection
repeated
CO2
L858R
supplementary
preferential
bromine
inhibitory
0001
NCS
radiological
161
angiogenesi
sumoharjo
ha
project
assembled
pubmed
theaccording
tein
schemescheme
hcl
NSCLC
0317
often
not
focu
crystalized
front
phase
before
may
propertie
nosi
pharm
boc2o
administrating
aqueou
stomach
group
erlotinib
welch
resonance
read
identical
113
853
NIRS
addition
same
rociletinib
context
need
synthe
260
brn2
syk
presented
135
shavrin
untangling
749
tetrahedron
zhang
upon
brine
review
LPDP
balatoni
investigation
II
confirmed
table
lepera
activation
them
diisopropylethylamine
attached
met790
wang
assume
month
NH
condensation
vivo
mori
marchevsky
mukhapadhyay
directly
education
schuit
laurent
sun
peptide
activity
destannylation
234
separate
liver
1603
over
stoke
niyonkuru
debromination
schopf
0300
gai
osaka
comp
ryuichi
molecule
other
133
minimize
200
substantially
KRAS
N3C
flore
debrominated
greatly
brominated
individualized
pyrimidine
disulfophenyl
copyright
1172
mecn
week
ametamey
february
org
detecting
solca
mobile
PEG3
direct
corporation
including
slight
149
9702
out
separated
log
novel
optimized
exces
studied
deliver
buffer
portuguez
done
study
instead
ice
two
radioiodine
mation
octanol
evaluated
guideline
CO
affibody
way
into
plasma
aimed
treatment
tributylstanny
kiyono
atmosphere
wako
suzuki
methoxyl
test
forming
fukui
cancer
445
suspended
compl
H441
independent
151
PEG
molecular
heelan
affect
1536012118823473
infinite
SO
phelp
jason
negligible
pao
alternative
cor
sealed
chelating
most
compared
ICO
6359
proliferation
mide
HRMS
dried
keyword
interaction
DMA
maintained
rajab
lated
andofsynthesi
added
thin
radiopharmaceutical
A1
pyrimidin
efficacy
1192
trifluoroacetic
brian
crossover
wild
writing
250
9854
scheme
sensitive
kogawa
between
633
march
passive
zhu
F200
T790M
secondary
kazuhiro
1074
water
regard
against
drug
synthesized
acetylpiperazin
vial
potency
concerning
free
transfor
doi
type
role
confirmation
16H05397
cortot
beneficial
planchard
pure
version
hepatobiliary
conceptualization
vein
labeling
8640
extracellular
chloro
murine
structure
T700
department
NN
acknowledge
van
mophenyl
methoxyphenyl
male
H15
provide
switzerland
declare
eur
throughout
did
2016
synthetic
yan
pharmaceutical
bearing
piperazine
influ
should
H3255
e17
H2N
some
mdpi
malignant
ykiyono
time
dinkelborg
865
hsu
jadhav
chromatogram
substituted
darmstadt
0178
nahco3
www
muscle
humidified
radioiodinated
riley
represent
2192
afatinib
3905
acknowledgment
almost
kyoto
thecell
reaction
enhance
necessary
patient
determined
design
lysate
monosodiu
0097
respectively
complex
recently
109
shiba
old
radioactive
cultured
radiobro
metastasi
REVIEW
NH2
131
short
kazuma
CT
ON
preclinical
capability
equipped
152
retained
NO2
alauddin
gradient
possessing
more
ECS400
2914
washiyama
radiopharm
decapitation
rikova
discussion
play
student
4563
resistance
region
acetic
apoptosi
administration
ICO1686
saline
HN
hydrophilicity
three
modifi
different
kakuma
acid
reported
supporting
proc
insuffi
recorded
exon
channel
applied
signalling
journal
mishiro
dioxane
861
shorter
KK
obr
however
116
modification
suggest
ICO16
confirm
also
license
level
solid
ID
dubinett
22h
subcutaneou
AP
naoh
tel
9276
tissue
600
penicillin
providing
agent
protocol
overexpression
original
CH
anilinopyrimidine
higher
day
wa
formal
successfully
source
128
industry
michael
anilinopyrim
expected
evaporation
counted
dichloromethane
found
shoulder
nonsmall
mutant
animal
well
854
locher
boc
radiotracer
ferl
young
NO
na2
cdcl3
information
increase
ohshima
177
resource
465
oxidizing
both77radiotracer
S2
institutional
metalation
651
six
kanai
1089
could
inhibition
butyl
2nd
6364
conflict
silica
toward
117
RP
optical
salt
chloride
accumulation
1608
selection
detected
agonist
note
diagnosi
poot
163
material
four
F254
republic
col
3390
comparing
room
brain
dinitrobenzene
targeted
231
positively
lux
collected
pan
meth
codon
contribute
kornhauser
zakowski
according
melanoma
editing
pal
substantial
targeting
percent
handling
akhter
fischer
strategy
stehle
shaken
bromobenzene
their
462
hinder
kev
scheme1
tween
milligram
radiohalogen
mutation
than
germany
uehara
therapy
such
phosphate
yarden
mainly
gonzalez
dichloro
creativecommon
kidney
acces
radiobrominated
C6
institution
4460
spectrometer
1311
suppression
2001
indonesia
carried
ministry
acridinium
exhibited
1210
0245205
residue
epidermal
related
signaling
terumo
contribution
anilinopyri
experiment
77fbr
120
yamaguchi
bromodestannylation
hydroxyacetophenone
ethan
song
9and
abstract
osimertinib
53508
introduction
plate
S4
caused
111
without
CF
118
iodine
priate
prominence
dicarbonate
334
xiao
kawai
berndorff
pattern
successively
kri
mean
119
index
ishikawa
H9
zhou
ortho
phenylalanine
universita
1218
described
supervision
double
jiang
mach
normal
compound
position
124
chemscene
tong
brclf3
bombardment
dose
injected
ofof
arnou
com
based
122
choi
270
H27
2015
bromophenyl
system
tively
committee
nonradioactive
analog
mizuno
165
precursor
retention
expressing
appro
received
stirred
hanaoka
breast
procedure
partition
approximately
nucleophilic
2CO
improved
oncotarget
radiosynthesi
slightly
under
crude
therapeutic
strongly
gene
BAMP
mol
discovery
920
kim
domain
layer
154
specific
both
146
although
TFA
137
30oc
acetonitrile
yin
brf3
core
pla
seimbille
bifunctional
140
boc2
later
DIPEA
washed
pharmacy
7010B
sncl2
radiolabeled
5SL
solvent
developed
kaleen
foundation
citation
hamamatsu
concentrated
kanbara
radiobromination
interested
incubation
BUDI
katzenellenbogen
fece
miller
9600
biopsy
structural
maennedorf
used
ECA600
271
previou
overcome
analyse
general
umi
256
studie
2005
prepared
production
expressed
intravenously
2006
oxy
cold
yellow
map
245
interfere
half
N7
lan
pressure
would
mater
77br
150
concentration
usable
spectra
manuscript
neoplasm
1070
followed
BAMT
model
acquisition
bodenstein
tracer
data
EGF
C27
density
statistically
amakino
radiobromine
pigmented
accepted
condition
2007
october
standard
impossible
right
nagamori
takeda
bromide
neck
heart
phenylbenzamide
varying
watanabe
supported
discov
presence
reverse
palpable
yoshimoto
weighed
dunnett
continued
institute
human
fujifilm
because
cosmosil
110
chloroform
adjusted
167
graduate
villen
compete
pro
8247
left
ethyl
abnormalitie
acquired
velikyan
ligand
might
jone
machi
3446
frontier
hydrochloric
2H2O
cellular
5493
acidic
rarely
chu
whole
term
mutated
non
masuda
substituent
5486
evaluate
tert
ANOVA
companion
number
ogawa
132
binding
tesque
longer
diaryliodonium
105
mice
statu
diluted
3121
mahmoud
mukhopadhyay
slobbe
statistical
S7
thr790
aminopyrimidine
suppose
gel
showed
oriuchi
fax
idine
reduced
fibronectin
scientific
completed
measurement
editor
colorles
difference
sawazaki
grant
ester
only
tributyltin
white
make
relatively
technology
O3
takara
MS
erbb
magnetic
amino
female
membrane
kitamura
2003
voller
attribution
185
rossin
bernard
per
perform
inc
dual
growth
celluptake
tomography
chain
parent
C16
progres
activating
multiple
tokyo
respec
MDPI
141
moreover
online
organ
nitrophenyl
completion
agreed
stable
published
insufficient
padera
pivotal
chemescene
yield
carry
detect
isocratic
wouldplaying
C14
koura
nitrogen
TLC
BY
sumida
while
inin
reached
mhz
IU
2013
BALB
lower
medical
ltd
awa
invasive
calculated
S3
med
SD
windhorst
assessment
important
achieved
invasion
USA
part
regarding
designing
H1975
influence
kiwada
affil
rev
seigo
expression
suggested
dastane
JEOL
692
286
muslim
highly
wasthe
space
conclusion
excretion
fund
sulfite
797
lopategui
FBS
kenji
fragment
adooq
O2N
1099
containing
chemistry
protein
2020
kozaka
size
soghomonyan
correspond
IRS
163723
cell
mbq
456
singh
affinity
initial
112
seen
first
910
corp
validation
blocking
national
PEER
implanted
untreated
ph14030256
WST
4571
determine
phosphatidylinositol
capelletti
cho
linker
acrylamide
spleen
promising
184
thesiscrystal
TKI
JMS
radiochemical
challenge
significantly
pale
vitro
wetzel
PEG6
quenched
recent
166
developing
commercially
counter
much
known
NBS
slow
year
labeled
liquid
191
gelovani
chemical
large
site
natl
organic
schubiger
lipophilicity
roelcke
delayed
endo
attractive
bruehlmeier
kinuya
gram
pharmacokinetic
194
OH
accordance
contrast
publisher
school
makino
analysi
using
mod
odani
7777
biodistribution
ofcommercially
widely
101
meanwhile
visualize
comparison
volgin
irvine
substitution
significance
chlorosuccinimide
hydrophobic
2018
center
matsuda
anhydrou
inhibitor
above
muammar
several
sigma
chromatography
informed
BCA
sacrificed
reader
methionine
maria
assessed
long
orange
synthesi
canada
138
nature
due
approval
occurred
development
intestine
F3C
altine
common
pathol
almutairi
take
basel
bromosuccinimi
following
request
106
walsum
mas
diag
selective
previ
er
desirable
through
diaminophenyl
659
generation
aromatic
accurate
bull
effective
directed
board
biological
science
SO4
sullivan
correspondence
rate
50h
incubated
kenneth
value
hexane
blaeuenstein
hence
pretreatment
nishii
ou
energy
9298
solution
LN
target
chirieac
niessen
ercan
interest
analyzed
kanto
F3
observed
author
meoh
gefitinib
flow
work
further
distributed
alpha
263
hitachi
136
imaging
charged
variety
kbq
friebe
liu
factor
bioscience
123
develop
TECAN
S6
CC
sliwkowski
recombinant
IPQA
EGFR
coefficient
cient
column
nacalai
S5
ic50to
gatekeeper
1179
unpaired
availability
53517
biol
sodium
organolithium
emission
situ
iation
produced
CH3
rmaceutical
derived
dongen
therefore
academic
purchased
maximal
deviation
network
improve
funding
summarized
purification
temperature
FAB
example
okuda
indicated
cellcell
pancrea
1686wasand
methanol
vortexed
O2N1
nat
shen
involved
liang
yokokawa
bioisostere
believed
2019
matsumoto
ing
cytotoxicity
comparable
C11
103
given
745
koshizawa
bioorganic
carcinoma
makassar
3436
fueger
syn
mentioned
treating
culture
697
smit
bromosuccinimide
O4
akira
diamine
1324
purified
atom
sathesh
open
OO
753
790
bind
introducing
detection
bone
low
min
tail
generated
available
methodology
provided
sport
bro
previously
threonine
then
key
statement
effect
met
reversed
5C18
http
acad
claim
ladanyi
ppargamma
method
licensee
article
180
chem
inage
streptomycin
O2
CD
varmu
determination
yun
creative
primary
sugo
antagonist
nardone
modulation
gamma
mouse
8555
research
oxidiz
guo
ATP
clearance
select
2188
857
1424
142
pulmonary
tumor
fluorine
cation
report
performance
indicate
blood
meaningles
CD3
metastatic
PBS
tominaga
specificity
tyrosine
accumulate
vesamicol
among
trifluoromethyl
2017
medium
extracted
introduced
thesi
H7
zhao
757
basi
nanogel
fundamentally
outstanding
acetate
plos
IC
antibody
stay
125
advanced
increased
fawwaz
lung
isolated
today
NMR
approved
2SO4
biomedical
419
receptor
CO1686
rapidly
HPLC
along
starting
predicting
preparation
iacob
predict
conducted
innocenti
product
consistent
chelation
microplate
afforded
smaller
pellikka
small
inof
endowment
removed
dissolved
tube
cleared
measured
associated
hydrogen
reliability
jurisdictional
ED
radionuclide
2011
butanol
nucl
auto
carbamate
uptake
tsushima
2021
significant
bromo
range
elst
CO3
asisderivative
ence
spectrometry
kinase
must
probe
ineffective
bromi
distribution
it
substantia
PET
2H2
mmol
kanazawa
2014
give
indirect
1193
response
ethanol
inoculation
warmed
QST
H3
after
kurobuchi
tin
one
crosslinker
afford
post
merck
positron
similar
yasushi
yeh
forozan
urip
gupta
transferred